Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | ELANIX |
Description | Search this site Skip to navigation ELANIX Biotechnologies Accueil Investor relations Company and ad hoc news Financial Reports DE ELANIX Biotechnologies |
Keywords | N/A |
WebSite | elanixbiotechnologies.ch |
Host IP | 84.16.66.164 |
Location | Switzerland |
Site | Rank |
US$318,961
Last updated: 2023-05-07 03:45:17
elanixbiotechnologies.ch has Semrush global rank of 33,183,794. elanixbiotechnologies.ch has an estimated worth of US$ 318,961, based on its estimated Ads revenue. elanixbiotechnologies.ch receives approximately 36,804 unique visitors each day. Its web server is located in Switzerland, with IP address 84.16.66.164. According to SiteAdvisor, elanixbiotechnologies.ch is safe to visit. |
Purchase/Sale Value | US$318,961 |
Daily Ads Revenue | US$295 |
Monthly Ads Revenue | US$8,833 |
Yearly Ads Revenue | US$105,993 |
Daily Unique Visitors | 2,454 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
elanixbiotechnologies.ch. 3600 | A | elanixbiotechnologies.ch. 3600 | IP: 84.16.66.164 |
elanixbiotechnologies.ch. 3600 | AAAA | elanixbiotechnologies.ch. 3600 | IPV6: 2001:1600:0:aaaa::2:14 |
elanixbiotechnologies.ch. 3600 | NS | elanixbiotechnologies.ch. 3600 | NS Record: ns32.infomaniak.com. |
elanixbiotechnologies.ch. 3600 | NS | elanixbiotechnologies.ch. 3600 | NS Record: ns31.infomaniak.com. |
elanixbiotechnologies.ch. 3600 | MX | elanixbiotechnologies.ch. 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
elanixbiotechnologies.ch. 3600 | MX | elanixbiotechnologies.ch. 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
elanixbiotechnologies.ch. 3600 | MX | elanixbiotechnologies.ch. 3600 | MX Record: 1 aspmx.l.google.com. |
elanixbiotechnologies.ch. 3600 | MX | elanixbiotechnologies.ch. 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
elanixbiotechnologies.ch. 3600 | MX | elanixbiotechnologies.ch. 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
elanixbiotechnologies.ch. 3600 | TXT | elanixbiotechnologies.ch. 3600 | TXT Record: google-site-verification=vwt1tSFO4x-35WofV8itOnSty1JI7EtDqenneMgIhcU |
elanixbiotechnologies.ch. 3600 | TXT | elanixbiotechnologies.ch. 3600 | TXT Record: v=spf1 include:zoho.com include:zoho.eu include:zohobooks.com include:_spf.google.com ~all |
elanixbiotechnologies.ch. 3600 | TXT | elanixbiotechnologies.ch. 3600 | TXT Record: google-site-verification=d33jUqUrYlM8bhcWA87z6hqwy0n3Tn1-TgpFeryLBIg |
elanixbiotechnologies.ch. 3600 | TXT | elanixbiotechnologies.ch. 3600 | TXT Record: p|https |
elanixbiotechnologies.ch. 3600 | TXT | elanixbiotechnologies.ch. 3600 | TXT Record: 1|www.elanixbiotechnologies.ch |
Search this site Skip to navigation ELANIX Biotechnologies Accueil Investor relations Company and ad hoc news Financial Reports DE ELANIX Biotechnologies Accueil Investor relations Company and ad hoc news Financial Reports DE More Accueil Investor relations Company and ad hoc news Financial Reports DE COMPANY WHO WE ARE? Elanix Biotechnologies is a tissue regeneration company specializing in burn and wound management. We develop and commercialize products for acute wound care. The Company is listed on the Frankfurt stock exchange under the symbol ELN. WHAT WE DO? Our philosophy to provide safe and innovative advanced skin care products. Office Elanix Biotechnologies AG c/o HEUKING KÜHN LÜER WOJTEK Georg-Glock-Str. 4 DE-40474 Düsseldorf Clic for contact Copyright © 2023 ELANIX Biotechnologies | Disclaimer | DE design by rjNet | rjScan.ch | Suisse Sàrl Report abuse Report |
HTTP/1.1 301 MOVED PERMANENTLY server: gunicorn date: Wed, 27 Oct 2021 06:35:46 GMT content-type: text/html; charset=utf-8 content-length: 279 location: https://www.elanixbiotechnologies.ch HTTP/2 200 content-type: text/html; charset=utf-8 x-frame-options: DENY cache-control: no-cache, no-store, max-age=0, must-revalidate pragma: no-cache expires: Mon, 01 Jan 1990 00:00:00 GMT date: Wed, 27 Oct 2021 06:35:47 GMT content-length: 75321 report-to: {"group":"AZM8irbjJqj1AV5BHD51MdaHh7lpD_Vlv2gcHw7IpJALMgk2VS4","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/encsid_AZM8irbjJqj1AV5BHD51MdaHh7lpD_Vlv2gcHw7IpJALMgk2VS4"}]} content-security-policy: base-uri 'self';object-src 'none';report-uri /_/view/cspreport;script-src 'nonce-NdkYrwtri4xlCpfMUftfIg' 'unsafe-inline' 'unsafe-eval';worker-src 'self';frame-ancestors https://google-admin.corp.google.com/ cross-origin-opener-policy-report-only: same-origin; report-to="AZM8irbjJqj1AV5BHD51MdaHh7lpD_Vlv2gcHw7IpJALMgk2VS4" referrer-policy: origin server: ESF x-xss-protection: 0 x-content-type-options: nosniff |